These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 9610609)
1. Hepatocarcinogenesis in liver cirrhosis: imaging diagnosis. Choi BI J Korean Med Sci; 1998 Apr; 13(2):103-16. PubMed ID: 9610609 [TBL] [Abstract][Full Text] [Related]
2. Small hepatocellular carcinomas and associated nodular lesions of the liver: pathology, pathogenesis, and imaging findings. Choi BI; Takayasu K; Han MC AJR Am J Roentgenol; 1993 Jun; 160(6):1177-87. PubMed ID: 8388618 [TBL] [Abstract][Full Text] [Related]
3. Diagnosing Borderline Hepatic Nodules in Hepatocarcinogenesis: Imaging Performance. Choi BI; Lee JM; Kim TK; Dioguardi Burgio M; Vilgrain V AJR Am J Roentgenol; 2015 Jul; 205(1):10-21. PubMed ID: 26102378 [TBL] [Abstract][Full Text] [Related]
4. Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules. Libbrecht L; Severi T; Cassiman D; Vander Borght S; Pirenne J; Nevens F; Verslype C; van Pelt J; Roskams T Am J Surg Pathol; 2006 Nov; 30(11):1405-11. PubMed ID: 17063081 [TBL] [Abstract][Full Text] [Related]
6. Discrimination of cirrhotic nodules, dysplastic lesions and hepatocellular carcinoma by their vibrational signature. Peng C; Kaščáková S; Chiappini F; Olaya N; Sandt C; Yousef I; Samuel D; Dumas P; Guettier C; Le Naour F J Transl Med; 2016 Jan; 14():9. PubMed ID: 26754490 [TBL] [Abstract][Full Text] [Related]
7. Hepatocarcinogenesis: imaging-pathologic correlation. Park YN; Kim MJ Abdom Imaging; 2011 Jun; 36(3):232-43. PubMed ID: 21267560 [TBL] [Abstract][Full Text] [Related]
8. Benign versus malignant hepatic nodules: MR imaging findings with pathologic correlation. Hussain SM; Zondervan PE; IJzermans JN; Schalm SW; de Man RA; Krestin GP Radiographics; 2002; 22(5):1023-36; discussion 1037-9. PubMed ID: 12235331 [TBL] [Abstract][Full Text] [Related]
9. Hepatocellular nodules in liver cirrhosis: MR evaluation. Lee JM; Choi BI Abdom Imaging; 2011 Jun; 36(3):282-9. PubMed ID: 21399975 [TBL] [Abstract][Full Text] [Related]
10. Detection of Endogenous Iron Reduction during Hepatocarcinogenesis at Susceptibility-Weighted MR Imaging: Value for Characterization of Hepatocellular Carcinoma and Dysplastic Nodule in Cirrhotic Liver. Li RK; Palmer SL; Zeng MS; Qiang JW; Chen F; Rao SX; Chen LL; Dai YM PLoS One; 2015; 10(11):e0142882. PubMed ID: 26605946 [TBL] [Abstract][Full Text] [Related]
11. A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis. Llovet JM; Chen Y; Wurmbach E; Roayaie S; Fiel MI; Schwartz M; Thung SN; Khitrov G; Zhang W; Villanueva A; Battiston C; Mazzaferro V; Bruix J; Waxman S; Friedman SL Gastroenterology; 2006 Dec; 131(6):1758-67. PubMed ID: 17087938 [TBL] [Abstract][Full Text] [Related]
12. Hepatocellular dysplastic nodules. Roncalli M; Borzio M; Di Tommaso L Ann Ital Chir; 2008; 79(2):81-9. PubMed ID: 18727269 [TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance of focal liver lesions in hepatic cirrhosis and chronic hepatitis. Martín J; Puig J; Darnell A; Donoso L Semin Ultrasound CT MR; 2002 Feb; 23(1):62-78. PubMed ID: 11866223 [TBL] [Abstract][Full Text] [Related]
14. Atypical large well-differentiated hepatocellular carcinoma with benign nature: a new clinical entity. Kudo M Intervirology; 2004; 47(3-5):227-37. PubMed ID: 15383732 [TBL] [Abstract][Full Text] [Related]
15. Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (<= 2.0 cm) in patients with hepatitis-induced liver cirrhosis. Park MJ; Kim YK; Lee MH; Lee JH Acta Radiol; 2013 Mar; 54(2):127-36. PubMed ID: 23148300 [TBL] [Abstract][Full Text] [Related]
16. [Clinicopathological significance of adenomatous hyperplasia of the liver]. Nakashima O; Kojiro M Nihon Rinsho; 1994 Jan; 52(1):75-9. PubMed ID: 8114314 [TBL] [Abstract][Full Text] [Related]
17. Importance of small (< or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver. Holland AE; Hecht EM; Hahn WY; Kim DC; Babb JS; Lee VS; West AB; Krinsky GA Radiology; 2005 Dec; 237(3):938-44. PubMed ID: 16306035 [TBL] [Abstract][Full Text] [Related]
18. Cirrhosis-associated hepatocellular nodules: correlation of histopathologic and MR imaging features. Hanna RF; Aguirre DA; Kased N; Emery SC; Peterson MR; Sirlin CB Radiographics; 2008; 28(3):747-69. PubMed ID: 18480482 [TBL] [Abstract][Full Text] [Related]
19. Arterial enhancing-only nodules less than 2 cm in diameter in patients with liver cirrhosis: predictors of hepatocellular carcinoma diagnosis on gadobenate dimeglumine-enhanced MR imaging. Quaia E; Pizzolato R; De Paoli L; Angileri R; Ukmar M; Cova MA J Magn Reson Imaging; 2013 Apr; 37(4):892-902. PubMed ID: 23097278 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic evaluation of hepatocellular carcinoma in a cirrhotic liver. Gogel BM; Goldstein RM; Kuhn JA; McCarty TM; Donahoe A; Glastad K Oncology (Williston Park); 2000 Jun; 14(6 Suppl 3):15-20. PubMed ID: 10887647 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]